Longboard pharmaceuticals to participate in five upcoming epilepsy-focused conferences this summer

San diego, june 01, 2022 (globe newswire) -- longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that members of its leadership team will participate in five upcoming events being hosted by respected epilepsy-focused patient advocacy groups.
LBPH Ratings Summary
LBPH Quant Ranking